Search Results

Filter
  • 1-10 of  423,576 results for ""Clinical Trials as Topic""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Optimizing pharmaceutical management of clinical trials.

  • Authors : Farhat A; Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Subjects: Pharmaceutical Preparations* ; Clinical Trials as Topic*; Humans

  • Source: Annales pharmaceutiques francaises [Ann Pharm Fr] 2024 Mar; Vol. 82 (2), pp. 285-291. Date of Electronic Publication: 2023 Dec 28.Publisher: Elsevier Masson Editeur Country of Publication: France NLM ID: 2985176R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Periodical

Move over, CRISPR: RNA-editing therapies pick up steam.

Subjects: Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/legislation & jurisprudence ; Clinical Trials as Topic*/Clinical Trials as Topic*/Clinical Trials as Topic*/standards ; CRISPR-Cas Systems*/CRISPR-Cas Systems*/CRISPR-Cas Systems*/genetics

  • Source: Nature [Nature] 2024 Feb; Vol. 626 (8001), pp. 933-934.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Clinical trials: Japan's opt-out policy raises risks of adverse drug responses.

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/legislation & jurisprudence ; Drug Approval*/Drug Approval*/Drug Approval*/methods ; Drug-Related Side Effects and Adverse Reactions*

  • Source: Nature [Nature] 2024 Feb; Vol. 626 (7998), pp. 261.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Periodical

Long COVID still has no cure - so these patients are turning to research.

Subjects: Post-Acute COVID-19 Syndrome*/Post-Acute COVID-19 Syndrome*/Post-Acute COVID-19 Syndrome*/therapy ; Post-Acute COVID-19 Syndrome*/Post-Acute COVID-19 Syndrome*/Post-Acute COVID-19 Syndrome*/virology ; Patients*/Patients*/Patients*/psychology

  • Source: Nature [Nature] 2024 Apr; Vol. 628 (8006), pp. 26-28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Current usage of explainer animations in trials: a survey of the UKCRC registered clinical trial units in the UK.

  • Authors : Barber VS; Oxford Clinical Trials Research Unit (OCTRU), University of Oxford, Oxford, UK. .; Calvert C

Subjects: Clinical Trials as Topic*; Humans ; Research Design

  • Source: Trials [Trials] 2024 Mar 28; Vol. 25 (1), pp. 224. Date of Electronic Publication: 2024 Mar 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

  • Authors : Kus T; Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep, Turkey.; Aktas G

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Clinical Trials as Topic*; Humans

  • Source: The oncologist [Oncologist] 2024 Mar 04; Vol. 29 (3), pp. 190-191.Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.

  • Authors : Smith KL; Sidney Kimmel Comprehensive Cancer Center, Women's Malignancies Disease Group, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Mead-Harvey C

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/therapy ; Pandemics* ; Clinical Trials as Topic*

  • Source: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7090.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Editorial Commentary: The Statistical Fragility Index of Medical Trials Is Low By Design: Critical Evaluation of Confidence Intervals Is Required.

Subjects: Confidence Intervals* ; Clinical Trials as Topic*; Humans

  • Source: Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association Publisher: W.B. Saunders Co Country of Publication: United States NLM ID: 8506498 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits.

  • Authors : Kilaru R; PPD, Part of Thermo Fisher Scientific, 929 North Front Street, Wilmington, NC, 28401-3331, USA. .; Amodio S

Subjects: Clinical Trials as Topic* ; Quality Control*; Humans

  • Source: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Mar; Vol. 58 (2), pp. 273-284. Date of Electronic Publication: 2023 Dec 26.Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  423,576 results for ""Clinical Trials as Topic""